JAZZ Related Earnings
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 2c; Guides Above the Street
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 11c; Issues FY13 Outlook
-
Jazz Pharmaceuticals, Inc. (JAZZ) Misses Q3 EPS by 3c; Guides Slightly Below the Street
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 4c
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 8c
-
Jazz Pharmaceuticals, Inc. (JAZZ) Reports In-Line Q3 EPS; Guides Above the Street
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 5c; Guides FY11
-
Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 2c; Boosts FY11 EPS Outlook
-
Jazz Pharmaceuticals (JAZZ) Tops Q4 Views; Guides FY11 Above Street
-
Today's Earnings Movers 11/05: WRLS, TTMI, IDSY, ATML, JAZZ Higher; DXCM, INSP, CCIX, SD, LPSN Lower
-
Jazz Pharmaceuticals (JAZZ) Resume Trading Up 8%
-
Jazz Pharma (JAZZ) Tops Q3 EPS by 7c, Guides Above the Street
-
Jazz Pharma (JAZZ) Posts Q2 adj.-EPS of $0.28, Tops Views; Increases FY10 Outlook
-
Jazz Pharma (JAZZ) Reports In-Line Q1 EPS, Sales Fall Short
-
Jazz Pharma (JAZZ) Posts Q4 EPS of $0.17, Tops by 10c; Guides FY10 EPS Above Street
-
Jazz Pharma (JAZZ) Swings to Q2 Profit; Guides FY09 Sales
-
Jazz Pharmaceuticals (JAZZ) Reports Large Q4 Loss
-
Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss of $2.17
-
Jazz Pharmaceuticals (JAZZ) Falls Short of Q1 Estimates By 40c
-
Jazz Pharmaceuticals(Nasdaq: JAZZ) Reports a Q4 Loss
-
Jazz Pharmaceuticals (JAZZ) Reports Q3 Loss of ($0.82)
Back to JAZZ Stock Lookup
